Is it really appropriate to continue to keep charging the taxpayer for those research risks on the back of an old product?
On the recordMay 8, 2019
Source
congress.govEditor's note · Context
Kennedy challenges the ongoing taxpayer funding for older products.
Share & report
More from Joseph P. Kennedy III
Jun 29, 2020
We are still reeling from the opioid crisis, which we never quite got our arms around. And I am just thinking that we are adding fuel to the fire here and that we should be very mindful of the fact that this is going to get, as we are…
Jul 13, 2020
It is not going to be a surprise to anybody in this committee--offshore wind development. This has been a priority of mine since I first arrived in Congress.
Jul 7, 2020
this pandemic has become a diagnostic dye tracing through our system, exposing deep inequities and injustice across our society.
Sep 22, 2020
COVID-19 has brought about unprecedented challenges to our healthcare system and our economy.





